Special Investigation in Patients With Ulcerative Colitis

Trial Profile

Special Investigation in Patients With Ulcerative Colitis

Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2018

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors AbbVie
  • Most Recent Events

    • 07 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 20 Oct 2017 Planned End Date changed from 31 Mar 2018 to 15 Feb 2018.
    • 20 Oct 2017 Planned primary completion date changed from 28 Jul 2017 to 15 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top